APA citiranje

Pavel, M., Baudin, E., Öberg, K., Hainsworth, J., Voi, M., Rouyrre, N., . . . Yao, J. (2017). Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: Final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 study. Ann Oncol.

Citação norma Chicago

Pavel, M.E., E. Baudin, K.E Öberg, J.D Hainsworth, M. Voi, N. Rouyrre, M. Peeters, D.J Gross, and J.C Yao. "Efficacy of Everolimus Plus Octreotide LAR in Patients With Advanced Neuroendocrine Tumor and Carcinoid Syndrome: Final Overall Survival From the Randomized, Placebo-controlled Phase 3 RADIANT-2 Study." Ann Oncol 2017.

MLA citiranje

Pavel, M.E., et al. "Efficacy of Everolimus Plus Octreotide LAR in Patients With Advanced Neuroendocrine Tumor and Carcinoid Syndrome: Final Overall Survival From the Randomized, Placebo-controlled Phase 3 RADIANT-2 Study." Ann Oncol 2017.